Happy Thanksgiving and belated Birthday, Senti! I feel your pain at another "poor" birthday gone bye, another year of holding tight the purse strings. This stock should have been on the rise years ago, at least on the significant progress and purchases the company has made! Little did we know that NWBO would have to invent, purchase or beg others to invent so many advancements in the process to approval: from biologics to manufacturing, from leukatherapis to immunotherapy, from closed system automation to automating records and validating inspections! It's been a crazy ride that's put us on the forefront of such signifcant change. And not just as observers. We've helped finance this historical change with the purchase of our many, many shares. And finally, we're almost there. The world will be a better place for all that NWBO has done, and not just in saving lives by beating cancers and prolonging lives. So much in biotechnology and clinical trials will be done better, safer, faster because of what we have helped to finance here.
I admit I have given up on trying to come up with a time when MHRA will approve (which I'm convinced will happen. Sorry, no inside info here). In less than a month it will have been a year since we submitted our application to the UK for marketing approval (December 20, 2023). We were all convinced this would be a quick turn around. Nothing about this process has resembled an attempt to stick to any timeline, let alone a fast-track 150 day timeline.
I hope that we and all who suffer from GBM will get a very special gift by Christmas. If not, I'll hope, as others here have, that the new Edens will be ready to start up when we finally hear from MHRA so we hit the ground running.
Happy Thanksgiving, everybody!
Bullish
AI
Market Data 
Markets 
